Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-15, with 51 holding rows worth $1,257,292,000.

Accession
0001425738-16-000040
Filed
2016-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 51 entries on the cover page, a total value of $1,257,292,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,257,292,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARRAY BIOPHARMA INC COM04269X105Stock16,658,072$112,442,000thousands by filing date
SEATTLE GENETICS INC812578102COM1,781,470$96,217,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM12,751,536$94,361,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM2,049,985$73,902,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS545,922$72,460,000thousands by filing date
INCYTE CORP COM45337C102Stock597,638$56,351,000thousands by filing date
PENUMBRA INC COM70975L107Stock672,918$51,135,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM778,160$45,382,000thousands by filing date
ENDOLOGIX INC29266S106COM3,480,644$44,552,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK662,286$44,406,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock2,021,617$43,242,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock701,659$42,078,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM640,400$39,327,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM737,900$38,976,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock464,077$31,075,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM2,138,471$29,276,000thousands by filing date
Boston Scientific Corporation101137107COM1,072,638$25,529,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,237,435$24,724,000thousands by filing date
NEVRO CORP64157F103COM227,267$23,724,000thousands by filing date
OPHTHOTECH CORP683745103COM505,154$23,303,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM702,539$23,022,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock701,822$22,788,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock916,927$20,823,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,431,119$17,975,000thousands by filing date
CHIMERIX INC COM16934W106Stock3,214,946$17,811,000thousands by filing date
MODEL N INC607525102COM1,550,959$17,231,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock916,626$14,903,000thousands by filing date
NEURODERM LTDM74231107ORD SHS805,246$14,889,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM892,782$11,736,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK714,692$11,206,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM127,106$10,593,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR288,356$9,475,000thousands by filing date
SPECTRANETICS CORP84760C107COM334,741$8,399,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK408,462$6,486,000thousands by filing date
VCA ANTECH INC918194101COM91,000$6,368,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM45,410$5,565,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK336,759$5,132,000thousands by filing date
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/04,000,000$4,761,000thousands by filing dateprincipal
INVITAE CORP46185L103COM510,369$4,471,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM1,425,158$4,446,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO575,863$3,841,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM27,539$818,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock187,610$565,000thousands by filing date
FIRST TR EXCHANGE-TRADED FD33733E203NY ARCA BIOTECH3,090$308,000thousands by filing date
UnitedHealth Group Inc91324P102COM1,820$255,000thousands by filing date
HUMANA INC COM444859102Stock1,390$246,000thousands by filing date
DEXCOM INC COM252131107Stock2,460$216,000thousands by filing date
BIOGEN INC COM09062X103Stock677$212,000thousands by filing date
ACHAOGEN INC004449104COM32,300$155,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock22,236$91,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock10,229$43,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001425738-16-000040this filing2016-11-15acceptance time not in the bulk data set